Sandbox: sadaf
Vitamin D deficiency Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Sandbox: sadaf On the Web |
American Roentgen Ray Society Images of Sandbox: sadaf |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
The mainstay of therapy for vitamin D deficiency is vitamin D.
Medical therapy
There are three forms of vitamin D; ergocalciferol (vitamin D2), cholecalciferol (vitamin D3), and calcitriol.
AAP recommends an initial phase of treatment with high dose of vitamin D for 2-3 months to treat vitamin D deficiency rickets. The recommended dose is 1000 IU/d in neonates, 1000-5000 IU/d in infants, and 5000 IU/d for children over 1-year-old. [1] After raising the serum 25 OHD levels to …., a maintenance dose of 400 IU/d is required for all age groups. Higher maintenance dose (800 IU/d) might be needed in at risk groups. [2]
An alternative strategy for treatment, also known as stoss therapy, is a single dose therapy in patients over 1-month-old. 100,000 – 600,000 IU of ergocalciferol orally single dose followed by maintenance therapy is recommended, especially in noncompliant patients. [3]
Special circumstances
- Patients on anticonvulsant drugs are at risk of vitamin D deficiency. If osteopenia occurs, treatment with 2000-4000 IU/d must be started. In case of osteomalacia, a larger dose of vitamin D, 5000-15000 IU/d is required. [4]
References
- ↑ Lee, Ji Yeon; So, Tsz-Yin; Thackray, Jennifer (2013). "A Review on Vitamin D Deficiency Treatment in Pediatric Patients". The Journal of Pediatric Pharmacology and Therapeutics. 18 (4): 277–291. doi:10.5863/1551-6776-18.4.277. ISSN 1551-6776.
- ↑ Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M (2008). "Vitamin D deficiency in children and its management: review of current knowledge and recommendations". Pediatrics. 122 (2): 398–417. doi:10.1542/peds.2007-1894. PMID 18676559.
- ↑ Shah BR, Finberg L (1994). "Single-day therapy for nutritional vitamin D-deficiency rickets: a preferred method". J. Pediatr. 125 (3): 487–90. PMID 8071764.
- ↑ Drezner MK (2004). "Treatment of anticonvulsant drug-induced bone disease". Epilepsy Behav. 5 Suppl 2: S41–7. doi:10.1016/j.yebeh.2003.11.028. PMID 15123011.